BANNER BEHAVIORAL HEALTH HOSPITAL
1. Target Overview & Investment Thesis
BANNER BEHAVIORAL HEALTH HOSPITAL is a 156-bed safety-net/medicaid heavy in MARICOPA, AZ with $44.0M in net patient revenue and a -15.5% operating margin. The hospital serves a payer mix of 2.8% Medicare, 50.1% Medicaid, and 47.1% commercial.
Thesis: Undervalued. Our ML models identify $3.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -15.5% to -8.1% (+736bps).
| Net Revenue HCRIS | $44.0M |
| Current EBITDA COMPUTED | $-6.8M |
| Operating Margin COMPUTED | -15.5% |
| Occupancy HCRIS | 62.5% |
| Revenue / Bed COMPUTED | $282K |
| Net-to-Gross HCRIS | 33.4% |
| Distress Probability ML | 57.5% |
2. Market Context & Competitive Position
AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of -15.5% places it below the state median. Among 42 size-comparable peers (78-312 beds), the median margin is -0.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (78-312), prioritizing same-state peers. 42 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BANNER BEHAVIORAL HEALTH HOSPI (Target) | AZ | 156 | $44.0M | -15.5% |
| HONORHEALTH JOHN C. LINCOLN ME | AZ | 258 | $618.4M | -7.9% |
| BANNER GATEWAY MEDICAL CENTER | AZ | 185 | $573.8M | 5.2% |
| VALLEYWISE HEALTH MEDICAL CENT | AZ | 301 | $509.4M | -50.0% |
| FLAGSTAFF MEDICAL CENTER | AZ | 242 | $477.9M | -0.8% |
| YAVAPAI REGIONAL MEDICAL CENTE | AZ | 218 | $456.9M | -2.2% |
| ABRAZO ARROWHEAD CAMPUS | AZ | 270 | $406.4M | 11.7% |
| MERCY GILBERT MEDICAL CENTER | AZ | 197 | $381.9M | 6.3% |
| KINGMAN REGIONAL MEDICAL CENTE | AZ | 196 | $373.6M | -6.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $923K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $879K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $870K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $535K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $28K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-6.8M |
| + RCM Uplift | +$3.2M |
| Pro Forma EBITDA | $-3.6M |
| Current Margin | -15.5% |
| Pro Forma Margin | -8.1% |
| WC Released (1x) | $1.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-10.5M | $-12.6M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-10.5M | $-17.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-9.4M | $-9.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-9.4M | $-13.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-11.5M | $-25.3M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-11.5M | $-31.6M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (50.1%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 57.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 42 hospitals with 78-312 beds
- Same-state prioritization (n=43)
- Comp margins: P25=-6.7% / P50=-0.3% / P75=12.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.